See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173313_2024_ABVC_Biopharma_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001173313, ABVC Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,656,709 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,969,278 |
| 3 | remainder_Assets | 4,866,612 |
| 4 | LiabilitiesCurrent | 5,932,490 |
| 5 | LiabilitiesNoncurrent | 407,457 |
| 6 | remainder_Liabilities | 21,680 |
| 7 | CostOfGoodsAndServicesSold | 302,145 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,699,785 |
| 9 | ResearchAndDevelopmentExpense | 1,163,839 |
| 10 | remainder_Expenses | 1,447,999 |
| 11 | remainder_Revenues | 591,165 |
| 12 | remainder_NetIncome | -1,851,314 |
| 13 | remainder_ComprehensiveNetIncome | 245,181 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,492,599 |
| 1 | Liabilities | 6,361,627 |
| 2 | Expenses | 7,613,768 |
| 3 | Revenues | 591,165 |
| 4 | StockholdersEquity | 8,130,972 |
| 5 | NetIncome | -8,873,917 |
| 6 | ComprehensiveNetIncome | -8,751,326 |
| 7 | BaseVar | 15,577,827 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.861 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
